跳至主要内容
临床试验/NCT00349505
NCT00349505Unknown2 期

Phase II Study of Intra-Peritoneal Hyper-Thermic Chemotherapy as Consolidation Therapy for Advanced Epithelial Ovarian Carcinoma

Gustave Roussy, Cancer Campus, Grand Paris2 个研究点 分布在 1 个国家目标入组 67 人开始时间: 2004年9月最近更新:
适应症

试验速览

阶段
2 期
入组人数
67
试验地点
2

研究概览

简要总结

Phase II to study results and morbidity of intra peritoneal hyper-thermic chemotherapy as consolidation therapy in patients with FIGO stage IIIC epithelial ovarian carcinoma treated by surgery and a total of 6 cycles of platinum based chemotherapy.

A second look operation is performed after treatment; during this second look secondary cytoreductive surgery is accepted without bowel resection.If none or milimetric peritoneal disease is obseved an intraperitoneal chemotherapy is achieve

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • epithelial ovarian carcinoma previous surgery + 6 cycles platinum based chemotherapy

排除标准

  • Patients ASA 3 patients with no residual tumor at first operation negative microscopic second look

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验